Webinar Summary – Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence
This summary was developed utilizing the full recorded presentation of this webinar, which is available on PsychU for all members free of charge. For full sourcing and polling results, please access the recording or the presentation slides at https://psychu.org/treatment-schizophrenia-focus-psychopharmacology-adherence/.
Two experts in the fields of psychiatry and psychopharmacology discussed medication adherence in the treatment of schizophrenia in a live webinar held on March 15, 2017. Henry A. Nasrallah, MD, is the Sydney W. Souers Professor and Chair of the Department of Psychiatry …
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.